Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06529094Not ApplicableRecruiting

Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic

Role: collaborator

NCT01710319Completed

Mechanisms of Immunosurveillance for Lung Cancer

Role: collaborator

NCT00806039Not ApplicableUnknown

Impact of Early Renal Involvement on the Development of Severe In-hospital Renal Failure

Role: lead

NCT00411294Completed

Ergocalciferol in Chronic Kidney Disease

Role: lead

All 4 trials loaded